Attached files

file filename
EX-99.1 - PRESS RELEASE - Advance Nanotech, Inc.ex99-1.htm


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________
 
FORM 8-K
_____________________

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  April 15, 2010

ADVANCE NANOTECH, INC.
(Exact name of registrant as specified in its charter)

Delaware
 
000-10065
 
20-1614256
(State or other jurisdiction
 
(Commission
 
(I.R.S. Employer
of incorporation)
 
File Number)
 
Identification No.)
 
     
400 Rella Blvd, Suite 160, Montebello, New York, NY
 
10901
(Address of principal executive offices)
 
(Zip Code)
 

Registrant's telephone number, including area code: (845) 533-4225

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
1

 

Item 2.02.            Results of Operations and Financial Condition.
 
On April 15, 2010, Advance Nanotech, Inc. (the “Company”) issued a press release announcing the Company’s results of operations for the year ended December 31, 2009. The press release is attached as Exhibit 99.1 hereto and is incorporated herein in its entirety.
 
The information included in this Item 2.02 of Current Report on Form 8-K, including the attached Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
 
 
Item 9.01.            Financial Statements and Exhibits.

d)
Exhibits
   
       
Exhibit Number
 
Description
       
99.1
 
Press Release, dated April 15, 2010.


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
     
 
ADVANCE NANOTECH, INC.
     
 
By:  
/s/ JON BUTTLES
 
Name: Jon Buttles
Title: Principal Executive Officer, Principal Financial Officer & Director
   
 
Dated: April 15, 2010

 
2

 

EXHIBIT INDEX

     
Exhibit No.
 
Description
99.1
 
Press Release, dated April 15, 2010 *
 
*        Filed herewith


3